IDDF2023-ABS-0224 Evaluating the changing trends in hepatocellular carcinoma cases in a multi-cultural australian tertiary hospital

BackgroundHepatocellular carcinoma (HCC) is increasing globally. Whilst viral hepatitis remains an important risk factor, the prevalence of the non-alcoholic fatty liver disease is rising and may become the leading cause of HCC. We evaluate the changing trends of HCC cases in our tertiary hospital w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gut 2023-06, Vol.72 (Suppl 1), p.A47-A47
Hauptverfasser: McNamara, Jack, Joseph, Raji, Stratton, Elisabeth, Levy, Miriam, Prakoso, Emilia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundHepatocellular carcinoma (HCC) is increasing globally. Whilst viral hepatitis remains an important risk factor, the prevalence of the non-alcoholic fatty liver disease is rising and may become the leading cause of HCC. We evaluate the changing trends of HCC cases in our tertiary hospital with a multi-cultural population.MethodsWe examined patients referred to HCC multi-disciplinary meeting at Liverpool Hospital in Sydney, Australia. Prospectively collected data were reviewed from the database.ResultsBetween January 2014 – December 2021, 530 new liver tumour cases were reviewed with 392 (74%) diagnosed as HCC. The mean age at diagnosis was 64 (range 21-89), with 312 (80%) of patients being male. Patients were identified as Caucasian (44.6%), Asian (31.9%), Middle-Eastern (6.4%), Polynesian (6.1%), Mediterranean (5.4%), Hispanic (4.8%), and others (0.8%).Primary liver disease of the new HCC cases were hepatitis C (34.2%), non-alcoholic steatohepatitis (NASH, 27.3%), hepatitis B (24.2%), alcohol (11.2%), and others (3.1%). 157 (40%) of new HCC cases were diagnosed under surveillance. Barcelona Clinic Liver Cancer staging at diagnosis was 0 in 11%, A in 18.9%, B in 29.8%, C in 30.1%, and D in 10.2%.There was a reduction in hepatitis C-related HCC since 2016. In 2016, 59% (n=23/39) of new HCC cases were related to hepatitis C vs 27% (n=17/63) in 2021. Conversely, there was an increase in NASH-related HCC, 10.3% (n=4/39) in 2016 vs 41.3% (n=26/63) in 2021. Only 28% (n=30/107) of NASH-related HCC were diagnosed on surveillance. There was a higher proportion of females in the NASH-related HCC cohort (34.6%, n=37/107) vs all HCC cases (20.4%, n=80/392).ConclusionsIn a tertiary hospital with a multi-cultural Australian cohort, the incidence of NASH-related HCC was rising and overtaking hepatitis C as the leading cause of HCC cases. Further research into the identification of at-risk groups is needed to improve outcomes.
ISSN:0017-5749
1468-3288
DOI:10.1136/gutjnl-2023-IDDF.32